MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2019 International Congress

    MIBG myocardial scintigraphy identifies premotor PD/DLB during a negative DAT scan period

    R. Sakakibara, F. Tateno, Y. Aiba (Sakura, Japan)

    Objective: It is unknown which marker is useful to identify the premotor phase PD/DLB. We recently reported four patients who, during a negative DAT scan…
  • 2019 International Congress

    Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, H. Nakajima, R. Sakakibara, S. Kuwabara, K. Hirata, M. Murai (Chiba, Japan)

    Objective: To evaluate the characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease (PD). Background: Lower gastrointestinal tract dysfunction is common in patients…
  • 2019 International Congress

    Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease

    X. Chai, S. Diwakarla, R. Pustovit, R. Mcquade, M. Di Natale, C. Ermine, C. Parish, D. Finkelstein, J. Furness (Melbourne, Australia)

    Objective: To characterize the gastrointestinal (GI) phenotype in the 6-hydroxydopamine (6OHDA) rat model of Parkinson’s disease (PD). Background: GI dysfunction, such as prolonged GI transit…
  • 2019 International Congress

    A Prospective Study of the Effects of Deep Brain Stimulation on Constipation and Olfaction in Parkinson Disease

    S. Kola, A. Bharucha, D. Prichard, K. Feuerhak, A. Hassan (Rochester, MN, USA)

    Objective: To investigate the effects of subthalamic nucleus deep brain stimulation (STN-DBS) on constipation and olfaction in patients with Parkinson disease (PD). Background: STN-DBS is…
  • 2019 International Congress

    Gastrointestinal microbiome in Parkinson’s disease in a Bavarian cohort

    F. Marxreiter, A. Cosma-Grigorov, H. Gassner, H. Meixner, Z. Kohl, M. Neurath, S. Wirtz, J. Winkler (Erlangen, Germany)

    Objective: Our goal was to evaluate, whether gut microbiota are altered in a Southern German PD cohort. In addition, we assessed changes in the microbiome…
  • 2018 International Congress

    Pain is correlated with other motor and non-motor symptom in Parkinson’s disease

    Y. Liu, X.Y. Zhu, X.J. Zhang, S.L. Yang, T.Y. Feng, Y.C. Wu (Shanghai, China)

    Objective: Study pain occurrence and appearance in Parkinson’s disease (PD), and its relationship with other motor and non-motor symptoms like constipation and footsteps. Background: The…
  • 2018 International Congress

    Gut microbiota geography in Parkinson’s disease in the world

    M. Hirayama, T. Maeda, T. Minato, M. Itoh, J. Takeda, T. Hamaguchi, M. Katsuno, K. Ohno (Nagoya, Japan)

    Objective: The 16 rRNA analysis and the shotgun metagenome analysis in our cohort were compared with 5 previous reports by others. Background: In PD patients,…
  • 2018 International Congress

    Objective intestinal dysfunction in REM sleep behaviour disorder

    K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, AM. Haase, M. Otto, K. Svendsen, K. Ostergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

    Objective: To study objectively measured intestinal function, defined by intestinal volume, transit times, and colonic motility patterns in patients with idiopathic REM sleep behaviour disorder…
  • 2018 International Congress

    Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease

    Y. Xiaodong, Q. Yiwei, X. Shaoqing, C. Shengdi, X. Qin (Shanghai, China)

    Objective: Emerging evidences suggest that gut microbiota dysbiosis plays a role in Parkinson’s disease (PD). However, the alterations in fecal microbiome in Chinese PD patients…
  • 2018 International Congress

    A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson’s disease

    K.K. Chong, S.Y. Lim, M.A.A. A Manap, J.L. Lim, S.C. Low, S. K Mahadeva, A.H. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the effects of probiotics on constipation in PD, using a randomized controlled trial (RCT) design Background: Non-motor symptoms (NMS) cause significant disability…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley